Page 60
conferenceseries.
com
July 27-28, 2017 Vancouver, Canada
Plastic & Aesthetic Surgery
2
nd
International Conference on
Volume 3, Issue 2 (Suppl)
J Aesthet Reconstr Surg, an open access journal
ISSN:2472-1905
Plastic Aesthetic Surgery 2017
July 27-28, 2017
J Aesthet Reconstr Surg. 2017, 3:2
DOI: 10.4172/2472-1905-C1-003
Flap reconstruction of rectovaginal and rectourethral fistulas: A 20-years experience
Jeremie D Oliver
1
, Arya A Akhavan
2
, Z S Hammoudeh
1
, Eric D Hokenstad
1
, Nho V Tran
1
and
J A Occhino
1
1
Mayo Clinic, USA
2
UNC Medical Center, USA
Background:
Rectovaginal and rectourethral fistulas can occur secondary to obstetric complications, cancer and radiation,
inflammatory bowel disease, and previous surgery. They are highly distressing to the patient and are often refractory to treatment.
Flap reconstruction places vascularized tissue between the apertures, creating separation and aiding in healing. This is particularly
useful for complex cases refractory to standard techniques.
Aim:
The purpose of this study was to investigate the outcomes of flap reconstruction of rectovaginal and rectourethral fistulas in the
setting of complicating comorbidities.
Methods:
All patients at all Mayo Clinic hospitals who underwent flap reconstruction of a rectovaginal or rectourethral fistula between
January 1995 and December 2014 were identified. Patient demographics, surgical indications, and comorbidities were collected.
Operative and postoperative data were also collected, including flap type, length of hospital stay, 30-day complications, recurrences,
and follow-up time. Operative success was defined as definitive treatment of the fistula without recurrence within 6 months.
Results:
There were 59 patients who underwent 66 reconstructions. The 30-day postoperative complication rate was 59.1% across
all patients, primarily consisting of infection (13) and dehiscence (11), with only 1 partial flap loss and no mortality. The 6-month
success rate was 51.5% across all patients. Patients with fistula secondary to obstetric complications had significantly lower success
rates (11.1%, p=0.031). There were no other statistically significant differences in outcomes by etiology, history of radiation, flap type,
gender, or history of prior repair attempt.
Conclusions:
Flap reconstruction remains a valuable treatment option for complex or refractory rectovaginal, rectourethral, and
other GI-to-genitourinary or complex genitourinary-perineal fistulas. Many different flaps, including low-morbidity options such
as gracilis and Martius-type flaps, can successfully be used as first-line reconstructive options. Despite an initial success rate of 50%,
nearly all cases were able to be repaired after a single additional reconstructive procedure. Patients with GI-to-vaginal fistulas due to
obstetric complications had significantly lower success rates.
oliver.jeremie@mayo.eduSurgical correction of unicoronal synostosis: A new technique
Amir Daryani
Shahid Beheshti University of Medical Sciences, Iran
A
lthough referrals for non-syndromic frontal plagiocephaly have been increased during the past several years, successful surgical
repair of unicoronal synostosis (UCS) remains a challenge for craniofacial surgeons. Most surgical techniques followed to
correct supraorbital rim elevation and temporal constrictions are being noticed less and often require a secondary revision. But
this new technique consists of surgical correction the affected ipsilateral frontal, temporal and superior orbital rim areas in the first
operation. From 1995 to 2014 a total of 154 cases of UCS were operated. 91 patients were operated with standard technique while
the new technique was applied on 63. All patients were evaluated by Whitaker scoring system after surgery. Data analysis indicates a
significant difference between the results of two surgical techniques (p=0.007). None of the patients from the new technique group
required revision surgery. We believe that our new technique have less invasive osteotomy on the frontal bone and no manipulation
of the orbital bone, so provide sufficient bone graft and is applicable even for younger patients (<6 months).
aradaran@gmail.com